{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T20:40:02Z","timestamp":1713991202088},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T00:00:00Z","timestamp":1337731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"abstract":"<jats:p>Two cases of squamous cell carcinoma possibly related to exposure to pegylated liposomal doxorubicin are presented.<\/jats:p>","DOI":"10.1634\/theoncologist.2011-0280","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T00:48:26Z","timestamp":1337820506000},"page":"1594-1595","source":"Crossref","is-referenced-by-count":10,"title":["Squamous Cell Carcinoma of the Oral Tongue in Two Patients Previously Exposed to Long-Term Pegylated Liposomal Doxorubicin"],"prefix":"10.1093","volume":"17","author":[{"given":"Marcelo R.","family":"Bonomi","sequence":"first","affiliation":[{"name":"The Tisch Cancer Institute, Division of Hematology\/Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Misiukiewicz","sequence":"additional","affiliation":[{"name":"The Tisch Cancer Institute, Division of Hematology\/Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Posner","sequence":"additional","affiliation":[{"name":"The Tisch Cancer Institute, Division of Hematology\/Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Maki","sequence":"additional","affiliation":[{"name":"The Tisch Cancer Institute, Division of Hematology\/Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,5,23]]},"reference":[{"key":"2021122308244422400_B1","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.25089","article-title":"Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumors)","volume":"116","author":"Pieres de Camargo","year":"2010","journal-title":"Cancer"},{"key":"2021122308244422400_B2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/589865","article-title":"Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin","volume":"47","author":"Martin-Carbonero","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021122308244422400_B3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/annonc\/mdl484","article-title":"Pegylated liposomal doxorubicin HCL (PLD; Caelyx\/Doxil): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer","volume":"18","author":"Andreopoulou","year":"2007","journal-title":"Ann Oncol"},{"key":"2021122308244422400_B4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jnci\/djq484","article-title":"Delayed neoplastic and renal complications in women receiving long-term chemotherapy for recurrent ovarian cancer","volume":"103","author":"Muggia","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"15 suppl","key":"2021122308244422400_B5","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1200\/jco.2011.29.15_suppl.5557","article-title":"Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer","volume":"29","author":"Cannon","year":"2011","journal-title":"J Clin Oncol"},{"key":"2021122308244422400_B6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.oraloncology.2010.07.010","article-title":"A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by sub sites","volume":"46","author":"Turati","year":"2010","journal-title":"Oral Oncol"},{"key":"2021122308244422400_B7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00053170","article-title":"Tobacco smoking, alcohol consumption, and risk of oral cancer: A case-control study in Beijing, People's Republic of China","volume":"1","author":"Zheng","year":"1990","journal-title":"Cancer Causes Control"},{"key":"2021122308244422400_B8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.34.10.1394","article-title":"Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis","volume":"34","author":"Giardiello","year":"1993","journal-title":"Gut"},{"key":"2021122308244422400_B9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2021122308244422400_B10","first-page":"243","article-title":"Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes","volume":"7","author":"Harrington","year":"2001","journal-title":"Clinical Cancer Research"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2011-0280","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2011-0280","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/17\/12\/1594\/41860777\/oncolo_17_12_1594.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/17\/12\/1594\/41860777\/oncolo_17_12_1594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:28:48Z","timestamp":1713986928000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/17\/12\/1594\/6403267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,23]]},"references-count":10,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,5,23]]},"published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2011-0280","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,12,1]]},"published":{"date-parts":[[2012,5,23]]}}}